-
yesterday 22:34
-
-
-
-
-
-
-
Plant to produce COVID-19 vaccines under construction in Zhambyl rgn

TARAZ. KAZINFORM – After construction is completed, the pharmaceutical plant plans to produce COVID-19 vaccines, Kazinform correspondent reports.
The biopharmaceutical plant is said to be under construction in Gvardeysk urban village, Korday district, Zhambyl region. After the construction is completed, which started in June, the Research Institute for Biological Safety Problems’ plant is set to produce vaccines against the COVID-19 virus.
Despite the construction is two weeks behind the schedule, the plant is planned to be launched by the end of 2020. It is said that the plant’s employees will be provided with flats as the residential building for 60 households is under construction as well.
The plant is set to produce immune-biological pharmaceuticals in line with international standards and good manufacturing practices (GMP), including COVID-19 vaccines developed by the scholars from the Research Institute for Biological Safety Problems. Vaccines against pandemic influenza, TB, brucellosis, Werther disease, pest of small ruminants, sheep and goat contagious ecthyma, sheep pox, rabies, and other infectious diseases will be produced as well.
The plant is expected to produce 60 million doses of pharmaceuticals a year.
- 1,445 more Kazakhstanis beat coronavirus
- Kazakhstan’s coronavirus tally climbs to 179,720
- 840 under treatment for COVID-19 at Tengiz oilfield
- 100 mln COVID-19 cases worldwide expected this week: WHO chief
-
4 passengers of Dubai-Almaty flight test positive for COVID-19
-
COVID incidence in pregnant women higher than in general population, Health Ministry says
- Speeches of the President of the Republic of Kazakhstan
- President's Address to the Nation
- Development of the President's Message
- Foreign Mass Media about Kazakhstan
- World and Crisis